glp-1 drug tirzepatide GLP-1/GIP Rx Bumps and humps in the

An agonist is a substance that activates a receptor in the body

More recently, clinicians have begun exploring their use in patients with Type 1 diabetes, particularly those with obesity, insulin resistance or features of metabolic syndrome

given the known effects of GLP-1RAs on GFAP in the models of DR, it is plausible for a direct effect of GLP-1RAs on Mller cells activation in the context of glaucoma

With thoughtful nutrition, close monitoring, and coordination with your healthcare provider, mothers can continue breastfeeding while using tirzepatide

Get irrefutable data about your diet and lifestyle by using your own glucose data with Vivelys CGM Program

J Neuroendocrinol 2022